Cite
Cherney DZI, McGuire DK, Charbonnel B, et al. Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV. Circulation. 2020;143(6):602-605doi: 10.1161/CIRCULATIONAHA.120.051901.
Cherney, D. Z. I., McGuire, D. K., Charbonnel, B., Cosentino, F., Pratley, R., Dagogo-Jack, S., Frederich, R., Maldonado, M., Liu, J., Pong, A., Liu, C. C., Cannon, C. P. (2021). Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV. Circulation, 143(6), 602-605. https://doi.org/10.1161/CIRCULATIONAHA.120.051901
Cherney, David Z I, et al. "Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV." Circulation vol. 143,6 (2021): 602-605. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051901
Cherney DZI, McGuire DK, Charbonnel B, Cosentino F, Pratley R, Dagogo-Jack S, Frederich R, Maldonado M, Liu J, Pong A, Liu CC, Cannon CP. Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV. Circulation. 2021 Feb 09;143(6):602-605. doi: 10.1161/CIRCULATIONAHA.120.051901. Epub 2020 Nov 13. PMID: 33186063.
Copy
Download .nbib